Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page. This does not affect the study data or public content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous v3.6.3. This update indicates a version bump in the page's revision history.SummaryDifference0.0%

- Check52 days agoChange DetectedThe revision in the history was updated from v3.6.2 to v3.6.3. This represents a new site version rather than changes to the trial data or content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated revision label for the page history.SummaryDifference0.0%

- Check74 days agoChange DetectedThe record adds a recruitment status noting that no participants are being sought, and a new revision tag (v3.6.0) replaces the previous revision (v3.5.5) in the history.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history shows that Revision: v3.5.5 was added and Revision: v3.5.4 was removed, indicating a small update to the page's version history.SummaryDifference0.0%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.